ASX:4DXHealthcare Services
How 4DMedical’s New CFO‑Executive Director Appointment At 4DMedical (ASX:4DX) Has Changed Its Investment Story
On January 2, 2026, 4DMedical Limited appointed early investor and long‑serving Non‑Executive Director Julian Sutton as both Executive Director and Chief Financial Officer on a three‑year term.
Sutton’s move into an executive role comes just after 4DMedical secured FDA clearance for CT:VQ™, U.S. deployments, and a global distribution agreement with Philips, concentrating financial and commercial leadership at a critical commercialisation phase.
Next, we’ll examine how elevating Sutton to CFO...